USRE30473EExpiredUtility

Benzophenone glycinamide derivatives

Priority: Jul 20, 1974Filed: Jul 31, 1978Granted: Jan 6, 1981
Est. expiryJul 20, 1994(expired)· nominal 20-yr term from priority
C07K 5/06191C07D 213/50C07D 249/08C07D 243/24C07K 5/06078C07K 5/06026C07K 5/06086C07K 5/06034C07K 5/06043C07K 5/06165A61K 38/00C07K 5/06104C07K 5/06095
16
PatentIndex Score
3
Cited by
5
References
1
Claims

Abstract

This invention is directed toward pharmacologically active compounds of the formula ##STR1## wherein A represents a nitrogen atom which may be substituted by a methyl, cyclopropylmethyl, di(C 1-4 alkyl)aminoethyl, methoxymethyl or hydroxyethyl group and B represents a carbonyl group or A and B together represent a grouping of the formula ##STR2## in which R a represents a hydrogen or a lower alkyl or hydroxymethyl group and X represents a nitrogen atom or C-R b wherein R b represents a hydrogen atom or a lower alkyl or hydroxymethyl group; R represents a halogen atom or a nitro or trifluoromethyl group; R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents an acyl group derived from a naturally occurring amino acid (all such groups which contain an asymmetric carbon atom having the L- or D,L-configuration) and R 3 represents a phenyl, halophenyl or 2-pyridyl group and acid addition salts thereof. Also provided are methods for their preparation and intermediates thereof. These compounds exhibit activity as anticonvulsants, muscle relaxants and sedatives.

Claims

exact text as granted — not AI-modified
We claim: .[.1. A compound of the formula.]. ##STR24## .[.wherein R is selected from the group consisting of a halogen atom, nitro and a trifluoromethyl group; R 1  is a hydrogen atom or a lower alkyl group; R 2  is an acyl group derived from a naturally occurring amino acid; R 3  is selected from the group consisting of phenyl and halophenyl; and R 4  is selected from the group consisting of a hydrogen atom, a methyl, cyclopropylmethyl, di(C 1-4  alkyl) aminomethyl, methoxymethyl and a hydroxyethyl group and the acid addition 
     
        salts thereof..]. .[.2.  The compound of claim 1 wherein R is a chlorine, bromine or a nitro group; R 1  is a hydrogen atom; R 3  is a phenyl, o-fluorophenyl, o-chlorophenyl; and R 4  is a hydrogen atom, a methyl, diethylaminoethyl or methoxymethyl group, and acid addition salts thereof..]. .Iadd. 3. The compound: L-prolyl-N-(2-benzoyl-4-nitrophenyl)glycinamide. .Iaddend..Iadd. 4. The compound: L-lysyl-N-(2-benzoyl-4-chlorophenyl)-N-methylglycinamide. .Iaddend..Iadd. 5. The compound: L-phenylalanyl-N-(2-benzoyl-4-nitrophenyl)-glycinamide. .Iaddend..Iadd. 6. The compound: L-arginyl-N-(2-benzoyl-4-chlorophenyl)-N-methylglycinamide. .Iaddend. .Iadd. 7. L-arginyl-N-(2-benzoyl-4-chlorophenyl)glycinamide. .Iadd. 8. L-phenylalanyl-N-(2-benzoyl-4-chlorophenyl)-N-methyl-L-alaninamide. .Iaddend.

Join the waitlist — get patent alerts

Track USRE30473E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.